Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation.
作者信息
Lee Ji Yeon, Cha Bong Soo
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Korean Circ J. 2018 Jul;48(7):602-604. doi: 10.4070/kcj.2018.0120.
Abstract
摘要
相似文献
1
Effects of Combination Therapy of Statin and Thiazolidinedione on Vascular Inflammation.他汀类药物与噻唑烷二酮类药物联合治疗对血管炎症的影响
Korean Circ J. 2018 Jul;48(7):602-604. doi: 10.4070/kcj.2018.0120.
2
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.阿司匹林、他汀类药物和降压药物（复方药物成分）联合使用与冠心病患者血管发病率和死亡率的关系。
Am Heart J. 2013 Aug;166(2):282-289.e1. doi: 10.1016/j.ahj.2013.04.011. Epub 2013 Jun 15.
3
Efficacy and safety of statins and exercise combination therapy compared to statin monotherapy in patients with dyslipidaemia: A systematic review and meta-analysis.他汀类药物与运动联合治疗与他汀类药物单药治疗相比在血脂异常患者中的疗效和安全性：一项系统评价和荟萃分析。
Eur J Prev Cardiol. 2017 Jun;24(9):907-916. doi: 10.1177/2047487317691874. Epub 2017 Feb 13.
4
A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.一种非噻唑烷二酮类过氧化物酶体增殖物激活受体γ部分激动剂可抑制血管平滑肌细胞生长。
Eur J Pharmacol. 2003 Apr 18;466(3):225-34. doi: 10.1016/s0014-2999(03)01556-5.
5
Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy.沙格列汀在接受他汀类药物联合治疗的2型糖尿病患者中的疗效和安全性。
J Diabetes Complications. 2014 Nov-Dec;28(6):887-93. doi: 10.1016/j.jdiacomp.2014.07.006. Epub 2014 Jul 17.
6
New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.2型糖尿病的新进展：噻唑烷二酮类药物的联合治疗
Clin Ther. 2003 Jul;25(7):1895-917. doi: 10.1016/s0149-2918(03)80195-9.
7
Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.他汀类药物治疗、炎症与冠状动脉支架植入术后患者的冠状动脉事件复发
J Am Coll Cardiol. 2001 Dec;38(7):2006-12. doi: 10.1016/s0735-1097(01)01662-x.
8
Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies.基于18F-FDG PET/CT的他汀类药物治疗对动脉壁炎症的影响：一项介入性研究的系统评价和荟萃分析
J Clin Med. 2019 Jan 18;8(1):118. doi: 10.3390/jcm8010118.
9
Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
Coron Artery Dis. 2011 Aug;22(5):352-8. doi: 10.1097/MCA.0b013e328346b8a2.
10
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.系统评价：联合治疗与单药治疗血脂异常的比较疗效与危害
Ann Intern Med. 2009 Nov 3;151(9):622-30. doi: 10.7326/0003-4819-151-9-200911030-00144.
引用本文的文献
1
The effects of statin therapy on brain tumors, particularly glioma: a review.他汀类药物治疗对脑瘤（尤其是神经胶质瘤）的影响：综述。
Anticancer Drugs. 2023 Oct 1;34(9):985-994. doi: 10.1097/CAD.0000000000001533. Epub 2023 Jul 19.
本文引用的文献
1
Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT.吡格列酮联合中等剂量他汀类药物对动脉粥样硬化炎症的影响：使用连续FDG-PET/CT的随机对照临床试验
Korean Circ J. 2018 Jul;48(7):591-601. doi: 10.4070/kcj.2017.0029.
2
F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.F-18氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描对心脏和血管炎症及感染的成像
Br Med Bull. 2016 Dec;120(1):55-74. doi: 10.1093/bmb/ldw035. Epub 2016 Sep 10.
3
Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.他汀类药物作为动脉粥样硬化形成中的抗炎剂：分子机制及最近临床试验的启示。
Curr Pharm Des. 2012;18(11):1519-30. doi: 10.2174/138161212799504803.
4
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.辛伐他汀联合罗格列酮对代谢综合征患者炎症、氧化应激和动态血压的影响：SIROCO 研究。
Diabetes Obes Metab. 2012 Feb;14(2):181-6. doi: 10.1111/j.1463-1326.2011.01510.x. Epub 2011 Nov 3.
5
Pioglitazone and mechanisms of CV protection.吡格列酮与心血管保护的机制。
QJM. 2010 Apr;103(4):213-28. doi: 10.1093/qjmed/hcp168. Epub 2009 Dec 2.
6
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.吡格列酮与格列美脲对2型糖尿病患者冠状动脉粥样硬化进展的比较：PERISCOPE随机对照试验
JAMA. 2008 Apr 2;299(13):1561-73. doi: 10.1001/jama.299.13.1561. Epub 2008 Mar 31.
7
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.吡格列酮和/或辛伐他汀对高敏C反应蛋白升高的心血管高危患者的抗炎作用：PIOSTAT研究
J Am Coll Cardiol. 2007 Jan 23;49(3):290-7. doi: 10.1016/j.jacc.2006.08.054. Epub 2007 Jan 8.
8
Thiazolidinediones.噻唑烷二酮类
N Engl J Med. 2004 Sep 9;351(11):1106-18. doi: 10.1056/NEJMra041001.
9
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.普伐他汀对胆固醇水平正常的心肌梗死患者冠状动脉事件的影响。胆固醇与再发事件试验研究人员。
N Engl J Med. 1996 Oct 3;335(14):1001-9. doi: 10.1056/NEJM199610033351401.
10
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.普伐他汀预防高胆固醇血症男性冠心病。苏格兰西部冠心病预防研究组。
N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001.
Zotero 插件